Floatz logo

Sgm-101

Image

Leiden University Medical CenterPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

1 Active assets in the Image cohort.

Asset / SponsorPhaseRating
LNTH-2403
Radiopharm Theranostics, Ltd
Phase 1NR

Same molecule, other indications

Sgm-101 is also rated in:

rectal cancerDormant
BB
Indicative ·
64 / 100
View asset →
colorectal neoplasmDormant
B
Indicative ·
59 / 100
View asset →
metastasis from malignant tumor of colonDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →